作者:Matthew G. LaPorte、Dimas José da Paz Lima、Feng Zhang、Malabika Sen、Jennifer R. Grandis、Daniel Camarco、Yun Hua、Paul A. Johnston、John S. Lazo、Lynn O. Resnick、Peter Wipf、Donna M. Huryn
DOI:10.1016/j.bmcl.2014.09.001
日期:2014.11
Synthesis and SAR investigation of 2-guanidinoquinazolines, initially identified in a high content screen for selective STAT3 pathway inhibitors, led to a more potent analog (11c) that demonstrated improved anti-proliferative activity against a panel of HNSCC cell lines.
2-胍基喹唑啉的合成和 SAR 研究最初是在选择性 STAT3 通路抑制剂的高内涵筛选中发现的,产生了更有效的类似物 ( 11c ),该类似物表现出对一组 HNSCC 细胞系的抗增殖活性有所改善。